FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003756857> ?p ?o ?g. }

• W2003756857 endingPage "2276" @default.
• W2003756857 startingPage "2267" @default.
• W2003756857 abstract "Transient receptor potential, melastatin-2 (TRPM2) is a plasma membrane cation channel with important roles in sensory functions and promoting cell death. However, we demonstrated here that TRPM2 was present in the nuclei of MCF-7 and MDA-MB-231 human breast adenocarcinoma cells, and its pharmacologic inhibition or RNAi silencing caused decreased cell proliferation. Neither an effect on proliferation nor a localization of TRPM2 in the nucleus was observed in noncancerous HMEC and MCF-10A human mammary epithelial cells. Investigation of possible effects of TRPM2 function in the nucleus demonstrated that pharmacologic inhibition or RNAi silencing of TRPM2 in MCF-7 and MDA-MB-231 human breast adenocarcinoma cells caused up to 4-fold increases in DNA damage levels, as compared to noncancerous breast cells after equivalent treatments. These results indicate that TRPM2 has a novel nuclear function in human breast adenocarcinoma cells that facilitates the integrity of genomic DNA, a finding that is distinct from its previously reported role as a plasma membrane cation channel in noncancerous cells. In summary, we report here a novel effect promoted by TRPM2, where it functions to minimize DNA damage and thus may have a role in the protection of genomic DNA in breast cancer cells. Our study therefore provides compelling evidence that TRPM2 has a unique role in breast adenocarcinoma cells. Accordingly, these studies suggest that TRPM2 is a potential therapeutic target, where its pharmacologic inhibition may provide an innovative strategy to selectively increase DNA damage levels in breast cancer cells." @default.
• W2003756857 created "2016-06-24" @default.
• W2003756857 creator A5004841111 @default.
• W2003756857 creator A5058782121 @default.
• W2003756857 creator A5065644236 @default.
• W2003756857 creator A5066119773 @default.
• W2003756857 creator A5084478550 @default.
• W2003756857 date "2015-03-06" @default.
• W2003756857 modified "2023-10-16" @default.
• W2003756857 title "Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cells" @default.
• W2003756857 cites W1534752717 @default.
• W2003756857 cites W1537218374 @default.
• W2003756857 cites W1559892880 @default.
• W2003756857 cites W1974646832 @default.
• W2003756857 cites W1986354445 @default.
• W2003756857 cites W1992613793 @default.
• W2003756857 cites W1997953313 @default.
• W2003756857 cites W2006471221 @default.
• W2003756857 cites W2011725251 @default.
• W2003756857 cites W2025394363 @default.
• W2003756857 cites W2027491627 @default.
• W2003756857 cites W2032564685 @default.
• W2003756857 cites W2039341957 @default.
• W2003756857 cites W2041641034 @default.
• W2003756857 cites W2045605578 @default.
• W2003756857 cites W2054089231 @default.
• W2003756857 cites W2061176455 @default.
• W2003756857 cites W2073377673 @default.
• W2003756857 cites W2087665027 @default.
• W2003756857 cites W2088273049 @default.
• W2003756857 cites W2092629964 @default.
• W2003756857 cites W2103915598 @default.
• W2003756857 cites W2145599647 @default.
• W2003756857 cites W2159811968 @default.
• W2003756857 cites W2163699185 @default.
• W2003756857 cites W2165743783 @default.
• W2003756857 cites W2166786094 @default.
• W2003756857 cites W2167318614 @default.
• W2003756857 doi "https://doi.org/10.3892/ijo.2015.2919" @default.
• W2003756857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4383028" @default.
• W2003756857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25760245" @default.
• W2003756857 hasPublicationYear "2015" @default.
• W2003756857 type Work @default.
• W2003756857 sameAs 2003756857 @default.
• W2003756857 citedByCount "40" @default.
• W2003756857 countsByYear W20037568572015 @default.
• W2003756857 countsByYear W20037568572016 @default.
• W2003756857 countsByYear W20037568572018 @default.
• W2003756857 countsByYear W20037568572019 @default.
• W2003756857 countsByYear W20037568572020 @default.
• W2003756857 countsByYear W20037568572021 @default.
• W2003756857 countsByYear W20037568572022 @default.
• W2003756857 countsByYear W20037568572023 @default.
• W2003756857 crossrefType "journal-article" @default.
• W2003756857 hasAuthorship W2003756857A5004841111 @default.
• W2003756857 hasAuthorship W2003756857A5058782121 @default.
• W2003756857 hasAuthorship W2003756857A5065644236 @default.
• W2003756857 hasAuthorship W2003756857A5066119773 @default.
• W2003756857 hasAuthorship W2003756857A5084478550 @default.
• W2003756857 hasBestOaLocation W20037568571 @default.
• W2003756857 hasConcept C104317684 @default.
• W2003756857 hasConcept C119056186 @default.
• W2003756857 hasConcept C121608353 @default.
• W2003756857 hasConcept C143425029 @default.
• W2003756857 hasConcept C151495721 @default.
• W2003756857 hasConcept C155164980 @default.
• W2003756857 hasConcept C170493617 @default.
• W2003756857 hasConcept C190283241 @default.
• W2003756857 hasConcept C2781182431 @default.
• W2003756857 hasConcept C502942594 @default.
• W2003756857 hasConcept C530470458 @default.
• W2003756857 hasConcept C54355233 @default.
• W2003756857 hasConcept C552990157 @default.
• W2003756857 hasConcept C55493867 @default.
• W2003756857 hasConcept C86803240 @default.
• W2003756857 hasConcept C95444343 @default.
• W2003756857 hasConcept C96232424 @default.
• W2003756857 hasConceptScore W2003756857C104317684 @default.
• W2003756857 hasConceptScore W2003756857C119056186 @default.
• W2003756857 hasConceptScore W2003756857C121608353 @default.
• W2003756857 hasConceptScore W2003756857C143425029 @default.
• W2003756857 hasConceptScore W2003756857C151495721 @default.
• W2003756857 hasConceptScore W2003756857C155164980 @default.
• W2003756857 hasConceptScore W2003756857C170493617 @default.
• W2003756857 hasConceptScore W2003756857C190283241 @default.
• W2003756857 hasConceptScore W2003756857C2781182431 @default.
• W2003756857 hasConceptScore W2003756857C502942594 @default.
• W2003756857 hasConceptScore W2003756857C530470458 @default.
• W2003756857 hasConceptScore W2003756857C54355233 @default.
• W2003756857 hasConceptScore W2003756857C552990157 @default.
• W2003756857 hasConceptScore W2003756857C55493867 @default.
• W2003756857 hasConceptScore W2003756857C86803240 @default.
• W2003756857 hasConceptScore W2003756857C95444343 @default.
• W2003756857 hasConceptScore W2003756857C96232424 @default.
• W2003756857 hasIssue "5" @default.
• W2003756857 hasLocation W20037568571 @default.
• W2003756857 hasLocation W20037568572 @default.
• W2003756857 hasLocation W20037568573 @default.

• next